Coastal Investment Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History

Coastal Investment Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$407.69 - $446.08 $320,036 - $350,172	785 New	785 $328,000
Q1 2021 Apr 12, 2021	SELL	$207.02 - $241.31 $302,042 - $352,071	-1,459 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$207.01 - $276.09 $302,027 - $402,815	1,459 New	1,459 $345,000
Q3 2020 Oct 23, 2020	SELL	$255.65 - $303.1 $292,974 - $347,352	-1,146 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$225.48 - $295.8 $24,802 - $32,538	-110 Reduced 8.76%	1,146 $333,000
Q1 2020 Apr 23, 2020	SELL	$199.77 - $247.81 $82,305 - $102,097	-412 Reduced 24.7%	1,256 $299,000
Q4 2019 Feb 05, 2020	SELL	$166.71 - $223.91 $6,501 - $8,732	-39 Reduced 2.28%	1,668 $371,000
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $14,129 - $15,902	85 Added 5.24%	1,707 $290,000
Q2 2019 Aug 01, 2019	BUY	$164.61 - $190.37 $94,156 - $108,891	572 Added 54.48%	1,622 $299,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $171,916 - $204,435	1,050 New	1,050 $194,000

1,708

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.